Symposium Article| Volume 348, ISSUE 2, P129-134, August 2014

Systolic Blood Pressure Goals to Reduce Cardiovascular Disease Among Older Adults


      The 2014 Evidence-Based Guideline for the Management of High Blood pressure in Adults Report From the panel Members Appointed to the Eighth Joint National Committee (JNC 8) was recently published. This guideline recommended that older adults (≥60 years) without diabetes or chronic kidney disease with systolic blood pressure (SBP) ≥150 mm Hg or diastolic blood pressure (DBP) ≥90 mm Hg be initiated on antihypertensive medication with a treatment goal SBp/DBP <150/90 mm Hg. In contrast, the previous 3 JNC guidelines recommended treatment for these individuals be initiated at SBP/DBP ≥140/90 mm Hg with goal SBP/DBP <140/90 mm Hg. In this article, we review randomized trials of antihypertensive medication and observational data on SBP and DBP with cardiovascular outcomes among older adults, possible explanations underlying the different findings from these randomized trials and observational studies, and contemporary antihypertensive treatment patterns among older U.S. adults. In closing, we highlight future research needs related to hypertension and outcomes among older adults.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • He J.
        • Whelton P.K.
        Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials.
        Am Heart J. 1999; 138: 211-219
        • Stamler J.
        • Stamler R.
        • Neaton J.
        Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.
        Arch Intern Med. 1993; 153: 598-615
        • US Department of Commerce
        National Population Projections. 2012; (Available at:) (Accessed December 30, 2013): 2012
        • Carson A.P.
        • Howard G.
        • Burke G.L.
        • et al.
        Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis.
        Hypertension. 2011; 57: 1101-1107
        • Egan B.M.
        • Zhao Y.
        • Axon R.N.
        US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008.
        JAMA. 2010; 303: 2043-2050
        • Frohlich E.D.
        Detection, evaluation, and treatment of hypertension: JNC-5 (Joint National Committee on detection, evaluation, and treatment of high blood pressure).
        Heart Dis Stroke. 1993; 2: 459-460
        • Chobanian A.V.
        • Bakris G.L.
        • Black H.R.
        • et al.
        The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report.
        JAMA. 2003; 289: 2560-2572
      1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.
        Arch Intern Med. 1997; 157: 2413-2446
        • James P.A.
        • Oparil S.
        • Carter B.L.
        • et al.
        2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
        JAMA. 2014; 311: 507-520
        • Antman K.
        • Amato D.
        • Wood W.
        • et al.
        Selection bias in clinical trials.
        J Clin Oncol. 1985; 3: 1142-1147
        • Mancia G.
        • Fagard R.
        • Narkiewicz K.
        • et al.
        2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
        J Hypertens. 2013; 31: 1281-1357
        • Aronow W.S.
        • Fleg J.L.
        • Pepine C.J.
        • et al.
        ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
        Circulation. 2011; 123: 2434-2506
      2. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
        JAMA. 1991; 265: 3255-3264
        • Staessen J.A.
        • Fagard R.
        • Thijs L.
        • et al.
        Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
        Lancet. 1997; 350: 757-764
        • Beckett N.S.
        • Peters R.
        • Fletcher A.E.
        • et al.
        Treatment of hypertension in patients 80 years of age or older.
        N Engl J Med. 2008; 358: 1887-1898
        • Verdecchia P.
        • Staessen J.A.
        • Angeli F.
        • et al.
        Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.
        Lancet. 2009; 374: 525-533
        • Ogihara T.
        • Saruta T.
        • Rakugi H.
        • et al.
        Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study.
        Hypertension. 2010; 56: 196-202
        • JATOS Study Group
        Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
        Hypertens Res. 2008; 31: 2115-2127
        • Trial T.S.
        (Available at:) (2013. Accessed December 20, 2013)
      3. Optimal blood pressure and cholesterol targets for preventing recurrent stroke in hypertensives (esh-chl-shot). Available at: Accessed December 20, 2013.

        • Howard G.
        • Goff Jr., D.C.
        A call for caution in the interpretation of the observed smaller relative importance of risk factors in the elderly.
        Ann Epidemiol. 1998; 8: 411-414
        • Lewington S.
        • Clarke R.
        • Qizilbash N.
        • et al.
        Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.
        Lancet. 2002; 360: 1903-1913
        • Satish S.
        • Freeman Jr., D.H.
        • Ray L.
        • et al.
        The relationship between blood pressure and mortality in the oldest old.
        J Am Geriatr Soc. 2001; 49: 367-374
        • Voko Z.
        • Bots M.L.
        • Hofman A.
        • et al.
        J-shaped relation between blood pressure and stroke in treated hypertensives.
        Hypertension. 1999; 34: 1181-1185
        • Ogihara T.
        • Matsuoka H.
        • Rakugi H.
        Practitioner’s trial on the efficacy of antihypertensive treatment in elderly patients with hypertension II (PATE-hypertension II study) in Japan.
        Geriatr Gerontol Int. 2011; 11: 414-421
        • Harris T.B.
        • Feldman J.J.
        Implications of health status in analysis of risk in older persons.
        J Aging Health. 1991; 3: 262-284
        • Rockwood K.
        • Stadnyk K.
        • MacKnight C.
        • et al.
        A brief clinical instrument to classify frailty in elderly people.
        Lancet. 1999; 353: 205-206
        • Fried L.P.
        • Tangen C.M.
        • Walston J.
        • Cardiovascular Health Study Collaborative Research Group
        • et al.
        Frailty in older adults: evidence for a phenotype.
        Journals Gerontol A Biol Sci Med Sci. 2001; 56: M146-M156
        • Odden M.C.
        • Peralta C.A.
        • Haan M.N.
        • et al.
        Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty.
        Arch Intern Med. 2012; 172: 1162-1168
        • Guo F.
        • He D.
        • Zhang W.
        • et al.
        Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010.
        J Am Coll Cardiol. 2012; 60: 599-606
        • Bromfield S.
        • Bowling C.B.
        • Tanner R.
        • et al.
        Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988-2010.
        J Clin Hypertens. 2014; 16: 270-276